Startseite Improving Gram stain proficiency in hospital and satellite laboratories that do not have microbiology
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Improving Gram stain proficiency in hospital and satellite laboratories that do not have microbiology

  • Jeannette Guarner EMAIL logo , Cassandra Street , Margaret Matlock , Lisa Cole und Francoise Brierre
Veröffentlicht/Copyright: 22. September 2016
Veröffentlichen auch Sie bei De Gruyter Brill

Abstract

Background:

Consolidation of laboratories has left many hospitals and satellite laboratories with minimal microbiologic testing. In many hospitals and satellite laboratories, Gram stains on primary specimens are still performed despite difficultly in maintaining proficiency.

Methods:

To maintain Gram stain proficiency at a community 450-bed hospital with an active emergency room we designed bimonthly challenges that require reporting Gram staining and morphology of different organisms. The challenges consist of five specimens prepared by the reference microbiology laboratory from cultures and primary specimens. Twenty to 23 medical laboratory scientists participate reading the challenges. Results from the challenges are discussed with each medical laboratory scientists. In addition, printed images from the challenges are presented at huddle to add microbiology knowledge.

Results:

On the first three challenges, Gram staining was read correctly in 71%–77% of the time while morphology 53%–66%. In the last six challenges correct answers for Gram stain were 77%–99% while morphology 73%–96%.

Conclusions:

We observed statistically significant improvement when reading Gram stains by providing frequent challenges to medical laboratory scientists. The clinical importance of Gram stain results is emphasized during huddle presentations increasing knowledge and motivation to perform the test for patients.


Corresponding author: Jeannette Guarner, MD, Department of Pathology and Laboratory Medicine, Emory University, 1364 Clifton Rd, Atlanta, GA 30322, USA, Phone: +404-712-2631

  1. Author contributions:All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: None declared.

  3. Employment or leadership:None declared.

  4. Honorarium: None declared.

  5. Competing interests:The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. Sautter R, Thomson R. Consolidated clinical microbiology laboratories. J Clin Microbiol 2015;53:1467–72.10.1128/JCM.02569-14Suche in Google Scholar PubMed PubMed Central

2. Clinical-Laboratory-Improvement-Ammendments. Proficiency testing. 2008. Available at: https://www.cms.gov/Regulations-and-Guidance/Legislation/CLIA/downloads/cliabrochure8.pdf. Accessed: Feb 2016.Suche in Google Scholar

3. Munson E, Block T, Basile J, Hryciuk J, Schell R. Mechanisms to assess Gram stain interpretation proficiency of technologists at satellite laboratories. J Clin Microbiol 2007;45:3754–8.10.1128/JCM.01632-07Suche in Google Scholar PubMed PubMed Central

4. Goodyear N, Kim S, Reeves M, Astion M. A 2-year study of Gram stain competency assessment in 40 clinical laboratories. Am J Clin Pathol 2006;125:28–33.10.1309/40WD3015CH1RYH58Suche in Google Scholar

5. Church D, Melnyk E, Unger B. Quantitative Gram stain interpretation criteria used by microbiology laboratories in Alberta, Canada. J Clin Microbiol 2000;38:4266–8.10.1128/JCM.38.11.4266-4268.2000Suche in Google Scholar PubMed PubMed Central

6. Tunkel A, Hartman B, Kaplan S, Kaufman B, Roos K, Scheld W, et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis 2004;39:1267–84.10.1086/425368Suche in Google Scholar PubMed

7. Elbireer A, Jackson J, Sendagire H, Opio A, Bagenda D, Amukele T. The good, the bad, and the unknown: quality of clinical laboratories in Kampala, Uganda. PLoS One 2013;8:e64661.10.1371/journal.pone.0064661Suche in Google Scholar PubMed PubMed Central

8. Tissot F, Prod’hom G, Manuel O, Greub G. Impact of round-the-clock CSF Gram stain on empirical therapy for suspected central nervous system infections. Eur J Clin Microbiol Infect Dis 2015;34:1849–57.10.1007/s10096-015-2423-9Suche in Google Scholar PubMed

9. Shifflett G, Nwachukwu B, Bjerke-Kroll B, Kueper J, Koltsov J, Sama A, et al. The value of intraoperative Gram stain in revision spine surgery. Spine J 2015;15:2198–205.10.1016/j.spinee.2015.06.001Suche in Google Scholar PubMed

10. Yuan S, Astion M, Schapiro J, Limaye A. Clinical impact associated with corrected results in clinical microbiology testing. J Clin Microbiol 2005;43:2188–93.10.1128/JCM.43.5.2188-2193.2005Suche in Google Scholar PubMed PubMed Central

11. Parry C, White R, Ridgeway E, Corkill J, Smith G. The reproducibility of sputum gram film interpretation. J Infect 2000;41:55–60.10.1053/jinf.2000.0680Suche in Google Scholar PubMed

12. Bloch M, Cembrowski G, Lembesis G. Longitudinal study of error prevalence in Pennsylvania physicians’ office laboratories. J Am Med Assoc 1988;260:230–5.10.1001/jama.1988.03410020096036Suche in Google Scholar

Received: 2016-6-23
Accepted: 2016-8-2
Published Online: 2016-9-22
Published in Print: 2017-3-1

©2017 Walter de Gruyter GmbH, Berlin/Boston

Artikel in diesem Heft

  1. Frontmatter
  2. Editorials
  3. Targeting errors in microbiology: the case of the Gram stain
  4. Time for a holistic approach and standardization education in laboratory medicine
  5. Reviews
  6. Serum uric acid levels and risk of prehypertension: a meta-analysis
  7. Lactic acidosis: an update
  8. Mini Review
  9. Progress and impact of enzyme measurement standardization
  10. Opinion Paper
  11. Critical comments to a recent EFLM recommendation for the review of reference intervals
  12. IFCC Paper
  13. Quality Indicators in Laboratory Medicine: the status of the progress of IFCC Working Group “Laboratory Errors and Patient Safety” project
  14. Genetics and Molecular Diagnostics
  15. Evaluation and comparison of three assays for molecular detection of spinal muscular atrophy
  16. General Clinical Chemistry and Laboratory Medicine
  17. Risk analysis of the preanalytical process based on quality indicators data
  18. Analytical and clinical validation of the new Abbot Architect 25(OH)D assay: fit for purpose?
  19. Looking beyond linear regression and Bland-Altman plots: a comparison of the clinical performance of 25-hydroxyvitamin D tests
  20. Next-generation osmotic gradient ektacytometry for the diagnosis of hereditary spherocytosis: interlaboratory method validation and experience
  21. Diagnosis of sphingolipidoses: a new simultaneous measurement of lysosphingolipids by LC-MS/MS
  22. Monitoring nicotine intake from e-cigarettes: measurement of parent drug and metabolites in oral fluid and plasma
  23. Development of a rapid and quantitative lateral flow assay for the simultaneous measurement of serum κ and λ immunoglobulin free light chains (FLC): inception of a new near-patient FLC screening tool
  24. A real-world evidence-based approach to laboratory reorganization using e-Valuate benchmarking data
  25. Cancer Diagnostics
  26. Utility of proGRP as a tumor marker in the medullary thyroid carcinoma
  27. Cardiovascular Diseases
  28. Can non-cholesterol sterols and lipoprotein subclasses distribution predict different patterns of cholesterol metabolism and statin therapy response?
  29. Infectious Diseases
  30. Improving Gram stain proficiency in hospital and satellite laboratories that do not have microbiology
  31. Diabetes
  32. Volumetric absorptive microsampling at home as an alternative tool for the monitoring of HbA1c in diabetes patients
  33. Corrigendum
  34. EFLM Recommendation
  35. Corrigendum to: Recommendation for the review of biological reference intervals in medical laboratories
  36. Letters to the Editor
  37. Evaluation of the trueness of serum alkaline phosphatase measurement in a group of Italian laboratories
  38. Innovative software for recording preanalytical errors in accord with the IFCC quality indicators
  39. Mixing studies for abnormal coagulation screen – the current trend
  40. Identification of 5-fluorocytosine as a new interfering compound in serum capillary zone electrophoresis
  41. How to define reference intervals to rule in healthy individuals for clinical trials?
  42. Evaluation of the performance of INDEXOR® in the archive unit of a clinical laboratory: a step to Lean laboratory
  43. Evaluation of an automated chemiluminescent immunoassay for salivary cortisol measurement. Utility in the diagnosis of Cushing’s syndrome
  44. Analysis of hemolysis, icterus and lipemia in arterial blood gas specimens
  45. Comparison of three routine insulin immunoassays: implications for assessment of insulin sensitivity and response
Heruntergeladen am 5.11.2025 von https://www.degruyterbrill.com/document/doi/10.1515/cclm-2016-0556/html
Button zum nach oben scrollen